Back to Search

Tildrakizumab – Uses, Dosage, and Brands in UAE

Brand Name: ILUMYA
Strength: 100 mg/1ml | Form: Solution For Injection
Price in UAE: AED 16211.50
Available in UAE pharmacies

About Tildrakizumab

Class: | Monoclonal antibody (IL-23 inhibitor) Use: | Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Adult dose: | Initial dose: 100 mg subcutaneously at week 0 and week 4; Maintenance dose: 100 mg subcutaneously every 12 weeks thereafter Pediatric dose: | Safety and efficacy have not been established in pediatric patients under 18 years of age Side effects: | Common side effects include injection site reactions, upper r

Drug Class

Monoclonal antibody (IL-23 inhibitor)

Uses & Indications

Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy

Storage Requirements

Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for a maximum of 14 days

Manufacturer & Packaging

Manufacturer: HIKMA PHARMACEUTICALS, AMMMAN, JORDAN, Jordan

Package Size

1 Pre-Filled Syringe (1 mL)

Price & Supplier

Price in UAE: AED 16211.50

Dosage Information

Adult Dose

Initial dose: 100 mg subcutaneously at week 0 and week 4; Maintenance dose: 100 mg subcutaneously every 12 weeks thereafter

Pediatric Dose

Safety and efficacy have not been established in pediatric patients under 18 years of age

Side Effects

Common side effects include injection site reactions, upper respiratory infections, headache, and fatigue

Contraindications & Precautions

Hypersensitivity to tildrakizumab or any component of the formulation; active infections, including tuberculosis

Important Warnings

Risk of serious infections; monitor for signs and symptoms of infection; may cause hypersensitivity reactions; not recommended for use in patients with active tuberculosis or other serious infections

Related Medicines in Same Category

See also: Other Monoclonal antibody (IL-23 inhibitor) medicines available in UAE pharmacies

Guselkumab (TREMFYA) Mirikizumab Mirikizumab 100 mg/1 Pen Mirikizumab 300mg/ 1 Vial Risankizumab Risankizumab Risankizumab Risankizumab

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Monoclonal antibody (IL-23 inhibitor) Medicines Browse All Categories